University of Helsinki - A Leading European University

Europe’s leading pharmaceutics researchers convened in Meilahti

The University of Helsinki leads a project to search for new cancer and other medicines.

Europe’s leading pharmaceutics researchers convened in Meilahti for the Helsinki Drug Research 2006 conference on 1-2 June.

One of the main topics of the conference was the half-way evaluation of a drug research project directed by the Faculty of Pharmacy at the University of Helsinki and financed by the EU. The project searches for new drugs for cancer, rejection reactions in organ transplants and central nervous system diseases, for instance.

All in all, more than 200 researchers and 23 research teams in 11 European countries participate in the research directed by the University of Helsinki.

“This is the second major EU research project directed by Finns. We are very ambitious about our role,” says Professor Raimo Tuominen, who coordinates the project.

The five-year project mainly focuses on research into protein kinases, which are a new, promising target for medical treatment.

“The new knowledge generated by this project will create the foundation for new drugs that can in the future help thousands of patients," says Tuominen.

Drugs developed based on the research results from this project can be expected on the market in ten years at the earliest.

More information on the project and the conference is available at www.proteinkinase-research.org.

Text: Mirja Mäenpää
Photo: Veikko Somerpuro
8.6.2006
www.helsinki.fi/digitalcommunications

Translation: Valtasana Oy

 Receive news via RSS feed >>
News of the month >>
News archive >>